Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

IMVT

Immunovant, Inc.

CIK 0001764013 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$41.09
↑ 0.78 (1.94%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Risks: Fundamentals, Options

Key stats

Market Cap
$8.44B
P/E Ratio
-16.69
EPS
-2.77
Dividend Yield
Not covered
52W Position
99%
Beta
1.49

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
9.89
P/S
Not covered
EV/Revenue
Not covered
ROE
-59.3%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 99%
$14.32$41.23

Latest Financials

2026-03-31 FY
Revenue
–
Net Income
-$505.61M
Total Assets
$957.01M
Free Cash Flow
-$407.32M

Recent news